Skip to content

Clinical trials

Completed Phase 1/2 Neuroectodermal Tumors, Primitive, Peripheral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors, Primitive, Peripheral Phase: Phase 1/2 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20071
20101
20141
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Duke University1
Eisai Inc.1
Fred Hutchinson Cancer Center1
University of Kentucky1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors, Primitive, Peripheral8
Rhabdomyosarcoma5
Sarcoma5
Neuroblastoma4
Central Nervous System Neoplasms3
Hodgkin Disease2
Lymphoma, Non-Hodgkin2
Osteosarcoma2
Ovarian Neoplasms2
Astrocytoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.